LXEO
Lexeo Therapeutics, Inc. Common Stock
NASDAQ: LXEO · HEALTHCARE · BIOTECHNOLOGY
$5.70
+0.26% today
Updated 2026-04-30
Market cap
$416.74M
P/E ratio
—
P/S ratio
478.26x
EPS (TTM)
$-1.86
Dividend yield
—
52W range
$2 – $11
Volume
0.9M
Lexeo Therapeutics, Inc. Common Stock (LXEO) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-55.00%
ROA
-32.90%
Debt/equity
0.07x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2020 | $518476.00 | $-5.15M | 100.00% | -884.86% | -993.83% |
| 2021 | $1.66M | $-50.62M | 100.00% | -3,055.94% | -3,055.04% |
| 2022 | $654000.00 | $-59.28M | 100.00% | -9,252.14% | -9,063.76% |
| 2023 | $0.00 | $-66.39M | — | — | — |
| 2024 | $0.00 | $-98.33M | — | — | — |
| 2025 | $0.00 | $-99.96M | — | — | — |